Prefrontal glutamate correlates of methamphetamine sensitization and preference

Kevin D. Lominac, Sema G. Quadir, Hannah M. Barrett, Courtney L. Mckenna, Lisa M. Schwartz, Paige N. Ruiz, Melissa G. Wroten, Rianne R. Campbell, Bailey W. Miller, John J. Holloway, Katherine O. Travis, Ganesh Rajasekar, Dan Maliniak, Andrew B. Thompson, Lawrence E. Urman, Tod E. Kippin, Tamara J. Phillips, Karen K. Szumlinski

Research output: Contribution to journalArticle

17 Scopus citations

Abstract

Methamphetamine (MA) is a widely misused, highly addictive psychostimulant that elicits pronounced deficits in neurocognitive function related to hypo-functioning of the prefrontal cortex (PFC). Our understanding of how repeated MA impacts excitatory glutamatergic transmission within the PFC is limited, as is information about the relationship between PFC glutamate and addiction vulnerability/resiliency. In vivo microdialysis and immunoblotting studies characterized the effects of MA (ten injections of 2 mg/kg, i.p.) upon extracellular glutamate in C57BL/6J mice and upon glutamate receptor and transporter expression, within the medial PFC. Glutamatergic correlates of both genetic and idiopathic variance in MA preference/intake were determined through studies of high vs. low MA-drinking selectively bred mouse lines (MAHDR vs. MALDR, respectively) and inbred C57BL/6J mice exhibiting spontaneously divergent place-conditioning phenotypes. Repeated MA sensitized drug-induced glutamate release and lowered indices of N-methyl-D-aspartate receptor expression in C57BL/6J mice, but did not alter basal extracellular glutamate content or total protein expression of Homer proteins, or metabotropic or α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptors. Elevated basal glutamate, blunted MA-induced glutamate release and ERK activation, as well as reduced protein expression of mGlu2/3 and Homer2a/b were all correlated biochemical traits of selection for high vs. low MA drinking, and Homer2a/b levels were inversely correlated with the motivational valence of MA in C57BL/6J mice. These data provide novel evidence that repeated, low-dose MA is sufficient to perturb pre- and post-synaptic aspects of glutamate transmission within the medial PFC and that glutamate anomalies within this region may contribute to both genetic and idiopathic variance in MA addiction vulnerability/resiliency.

Original languageEnglish (US)
Pages (from-to)689-702
Number of pages14
JournalEuropean Journal of Neuroscience
Volume43
Issue number5
DOIs
StatePublished - Mar 1 2016

    Fingerprint

Keywords

  • Addiction vulnerability
  • Homer proteins
  • Metabotropic glutamate receptor
  • Methamphetamine
  • NMDA receptor
  • Prefrontal cortex

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Lominac, K. D., Quadir, S. G., Barrett, H. M., Mckenna, C. L., Schwartz, L. M., Ruiz, P. N., Wroten, M. G., Campbell, R. R., Miller, B. W., Holloway, J. J., Travis, K. O., Rajasekar, G., Maliniak, D., Thompson, A. B., Urman, L. E., Kippin, T. E., Phillips, T. J., & Szumlinski, K. K. (2016). Prefrontal glutamate correlates of methamphetamine sensitization and preference. European Journal of Neuroscience, 43(5), 689-702. https://doi.org/10.1111/ejn.13159